🫀 Framingham Heart Risk Score – Estimate Your 10-Year CHD Risk
The Framingham Heart Risk Score (FRS) is one of the most widely validated tools in preventive cardiology. Developed from the landmark Framingham Heart Study — a long-running population cohort that began in 1948 — it estimates the probability that a person without existing heart disease will experience a hard coronary heart disease (CHD) event (heart attack or coronary death) over the next 10 years.
Clinicians use the score to guide decisions about lifestyle counselling, statin therapy, and blood pressure treatment thresholds. This calculator implements the NCEP ATP III point-scoring system (National Cholesterol Education Program Adult Treatment Panel III, 2001), which is sex-specific and age-stratified.
📊 Risk Factors Used in the Score
The ATP III algorithm considers five independent cardiovascular risk factors, each assigned age- and sex-adjusted point values:
| Risk Factor | Why It Matters |
|---|---|
| Age | CHD risk rises steeply with age; younger adults earn negative points that offset other risks. |
| Total Cholesterol | Higher LDL-driven total cholesterol accelerates atherosclerosis; points are lower at older ages because other factors dominate. |
| HDL Cholesterol | High-density lipoprotein is protective — a high HDL subtracts a point from your total, while a low HDL adds points. |
| Systolic Blood Pressure | Higher systolic pressure increases cardiac workload. Treated hypertension earns more points than untreated at the same level, reflecting residual risk. |
| Smoking | Current cigarette smoking significantly raises CHD risk, especially in younger adults (up to 9 extra points for women aged 20–39). |
🔢 How Points Map to 10-Year Risk
After summing all five component scores, the total is mapped to a 10-year risk percentage using sex-specific lookup tables. Men and women use different tables because the absolute risk at any given point total differs between sexes.
| Risk Category | 10-Year Risk | ATP III Implication |
|---|---|---|
| Low | <10% | Lifestyle changes are the primary focus; medication thresholds are higher. |
| Intermediate | 10–19% | Lifestyle intervention plus consideration of statin and BP therapy. |
| High | ≥20% | Treat with the same intensity as existing CHD — aggressive risk-factor management. |
🩺 Clinical Context & Limitations
The Framingham Risk Score was originally derived from a predominantly white American suburban cohort. Key limitations include:
- Ethnic generalisation: The model may over-estimate risk in some East Asian populations and under-estimate it in certain South Asian groups. The 2013 AHA/ACC Pooled Cohort Equations extend validation to African-Americans.
- Excluded conditions: Individuals with pre-existing CHD, stroke, peripheral artery disease, or type 2 diabetes are already classified as high risk and should not use this score.
- Emerging risk factors: The classic FRS does not account for C-reactive protein (CRP), coronary artery calcium (CAC) score, family history, or inflammatory markers — all of which clinicians may use to refine risk.
- Cholesterol units: Inputs must be in mg/dL. Multiply mmol/L values by
38.67before entering.
💡 Interpreting Your Result
A Framingham score is most useful as a starting point for a conversation with your doctor — not a definitive diagnosis. If your score is Intermediate, additional testing such as a high-sensitivity CRP or a coronary artery calcium CT scan can reclassify your risk and guide therapy more precisely.
The most modifiable risk factors in the score are smoking cessation (which removes smoking points immediately) and blood pressure control (which can shift multiple point brackets). Regular aerobic exercise and a heart-healthy diet improve HDL cholesterol over time, further reducing your total score.
Algorithm source: NCEP Expert Panel, JAMA 2001;285(19):2486-2497.